Surgical management of lymph-node-positive prostate cancer: Improves symptomatic control

BJU International

Volumn 107, Issue 8, 2011, Pages 1238-1242

  Wiegand, Lucas R ^a   Hernandez, Mike ^b   Pisters, Louis L ^b   Spiess, Philippe E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

local control; lymph node positive; prostate cancer; radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RELAPSE; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RADICAL RETROPUBIC PROSTATECTOMY; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79954544075     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09657.x     Document Type: Article

References (13)

1. Messing EM, Manola J, Yao J, et al,. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006; 7: 472-9 (Pubitemid 43779173)
2. Cheng L, Zincke H, Blute ML, Bergstralh EJ, et al,. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001; 91: 66-73 (Pubitemid 32052615)
3. Gjertson CK, Asher KP, Sclar JD, et al,. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era. Urology 2007; 70: 723-7 (Pubitemid 350030211)
4. Schumacher MC, Burkhard FC, Thalmann GN, et al,. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 2008; 54: 344-52. Epub 2008 May 21
5. Aus G, Hugosson J, Norlén L,. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J Urol 1995; 154: 466-9
6. Seidenfeld J, Samson DJ, Hasselblad V, et al,. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med 2000; 132: 566-77 (Pubitemid 30171897)
7. Grimm MO, Kamphausen S, Hugenschmidt H, et al,. Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation. Eur Urol 2002; 41: 628-34; discussion 634 (Pubitemid 35333920)
8. Frazier HA 2nd, Robertson JE, Paulson DF,. Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol 1994; 12: 308-12
9. Leibovici D, Lee AK, Cheung RM, et al,. Symptomatic local recurrence of prostate carcinoma after radiation therapy. Cancer 2005; 103: 2060-6 (Pubitemid 40605113)
10. Potosky AL, Knopf K, Clegg LX, et al,. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001; 19: 3750-7 (Pubitemid 32844788)
11. Wei JT, Gross M, Jaffe CA, et al,. Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology 1999; 54: 607-11 (Pubitemid 29449417)
12. Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR,. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 2007; 99: 1516-24. Epub 2007 Oct 9 (Pubitemid 351767235)
13. Spiess PE, Lee AK, Busby JE, et al,. Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome? Br J Urol 2007; 99: 321-5. Epub 2006 Nov 28 (Pubitemid 46110434)